Pharma Foods International Co., Ltd.

TSE:2929 Rapporto sulle azioni

Cap. di mercato: JP¥26.9b

Pharma Foods International Salute del bilancio

Salute finanziaria criteri di controllo 5/6

Pharma Foods International has a total shareholder equity of ¥11.6B and total debt of ¥16.9B, which brings its debt-to-equity ratio to 145.8%. Its total assets and total liabilities are ¥36.6B and ¥25.0B respectively. Pharma Foods International's EBIT is ¥5.1B making its interest coverage ratio 155. It has cash and short-term investments of ¥15.7B.

Informazioni chiave

145.8%

Rapporto debito/patrimonio netto

JP¥16.89b

Debito

Indice di copertura degli interessi155x
ContantiJP¥15.67b
Patrimonio nettoJP¥11.59b
Totale passivitàJP¥24.99b
Totale attivitàJP¥36.57b

Aggiornamenti recenti sulla salute finanziaria

Recent updates

Pharma Foods International Co., Ltd.'s (TSE:2929) Prospects Need A Boost To Lift Shares

Oct 31
Pharma Foods International Co., Ltd.'s (TSE:2929) Prospects Need A Boost To Lift Shares

We Think Pharma Foods International's (TSE:2929) Solid Earnings Are Understated

Sep 22
We Think Pharma Foods International's (TSE:2929) Solid Earnings Are Understated

Is Pharma Foods International (TSE:2929) Using Too Much Debt?

Jul 23
Is Pharma Foods International (TSE:2929) Using Too Much Debt?

We Like Pharma Foods International's (TSE:2929) Earnings For More Than Just Statutory Profit

Mar 23
We Like Pharma Foods International's (TSE:2929) Earnings For More Than Just Statutory Profit

Analisi della posizione finanziaria

Passività a breve termine: 2929's short term assets (¥27.3B) exceed its short term liabilities (¥23.2B).

Passività a lungo termine: 2929's short term assets (¥27.3B) exceed its long term liabilities (¥1.8B).


Storia e analisi del rapporto debito/patrimonio netto

Livello di debito: 2929's net debt to equity ratio (10.6%) is considered satisfactory.

Riduzione del debito: 2929's debt to equity ratio has increased from 72% to 145.8% over the past 5 years.

Copertura del debito: 2929's debt is well covered by operating cash flow (32.5%).

Copertura degli interessi: 2929's interest payments on its debt are well covered by EBIT (155x coverage).


Bilancio


Scoprire le aziende sane